WHO ICTRP trial
The analgesic effect of tegilalide in patients undergoing hysteroscopic surgery
ChiCTR2500104597 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2500104597 |
|---|---|
| Public title | The analgesic effect of tegilalide in patients undergoing hysteroscopic surgery |
| Scientific title | The analgesic effect of tegilalide in patients undergoing hysteroscopic surgery |
| Primary sponsor | The First Affiliated Hospital of Guangxi Medical University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Surgery and anesthesia |
| Interventions | Control group:Conventional general anesthesia;Test group:On the basis of the control group, 0.75mg of taglidine was administered intravenously during anesthesia induction. |
| Registration date | Jun 19, 2025 |
| Target size | Control group:50;Test group:50 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: